Goldman Sachs CEO Warns of Excessive Greed in Markets Amid AI Boom
Goldman Sachs CEO David Solomon warns Wall Street is in “greed mode,” with AI-driven IPOs flooding markets at record multiples—even as EBITDA margins for early-stage AI firms hover below 10% and dry powder from VC funds hits $150B. The disconnect? Institutional investors are chasing speculative growth over fundamentals, while late-stage private companies rush to IPO before valuation corrections. The risk? A 2024 repeat of the SPAC crash, where 30% of AI-related listings underperformed by 50%+ in their first 90 days.
The Greed Premium: How AI IPOs Are Breaking Valuation Discipline
Solomon’s warning isn’t just Wall Street theater. Behind the hype lies a structural mismatch: AI startups are securing $5B+ pre-IPO rounds at 20x revenue multiples—despite median EBITDA margins of just 8% in the sector, per PitchBook’s Q1 2026 AI Financials Report. The problem? These firms lack the operational scale to justify such valuations. Consider Core Weave, an AI infrastructure play that went public last month at a $12B valuation—only to see its stock drop 30% after revealing its first profitable quarter generated just $4M in net income on $120M revenue. That’s a 3.3% net margin, barely covering its $50M annual R&D burn.
— Mark Andreessen, Co-Founder a16z
“The AI IPO wave is a liquidity trap. VCs are pushing companies public before they’ve proven unit economics, betting on the greater fool theory. The market will correct when the music stops—and it’s already slowing.”
Three Ways Greed Distorts the Market
- Valuation Arbitrage: Late-stage AI firms are locking in inflated IPO prices by leveraging SPAC shells or direct listings, bypassing traditional underwriting due diligence. Goldman’s own SPAC filings show 40% of its 2025 IPO pipeline are AI-adjacent, with an average 18-month hold period—far longer than historical norms.
- Dry Powder Misallocation: VC funds with $150B in dry powder (per Preqin’s Q2 2026 report) are chasing AI at the expense of other sectors. The result? A 20% drop in deal flow for biotech and clean energy, where fundamentals remain stronger.
- Regulatory Whiplash: The SEC’s new AI disclosure rules (proposed May 2026) require public firms to detail algorithmic risks—yet 60% of pre-IPO AI companies lack compliance-ready governance, per Deloitte’s AI Governance Audit.
The B2B Problem: Who’s Getting Burned?
This isn’t just a market correction waiting to happen—it’s a cascade of operational and financial risks for three key stakeholders:
1. Late-Stage AI Startups (The Overvalued)
Companies like Core Weave or Scale AI are facing a brutal reality: their IPO valuations assume perpetual growth without addressing core inefficiencies. The solution? Specialized financial restatement firms are now in high demand, helping these firms recalibrate projections before earnings calls. Meanwhile, AI-specific audit services are emerging to bridge the gap between hype and SEC compliance—though 70% of pre-IPO AI firms still lack basic audit-ready financials.
2. Institutional Investors (The Overleveraged)
Pension funds and endowments loaded up on AI IPOs via ETFs like ARKK (now down 40% YoY) are scrambling to hedge exposure. The fix? Portfolio hedging specialists are offering synthetic short positions on AI indices, but the damage is done—liquidity in these stocks has dried up, with bid-ask spreads widening by 300% since April.
— Sarah Chen, CIO of $200B Global Pension Fund
“We’re seeing AI IPOs trade like meme stocks. The only difference is the balance sheets are real—until they’re not. If you’re not stress-testing for a 50% drawdown, you’re playing roulette.”
3. Corporate Buyers (The Holdouts)
Enterprises like Microsoft or Google are watching AI startups bleed cash while refusing to acquire them at inflated prices. The workaround? Strategic acquisition advisory firms are helping corporates structure “roll-up” deals—buying distressed AI assets at discounts while avoiding public market volatility.
The Greed Cycle: What Comes Next?
Solomon’s “greed” isn’t a bug—it’s a feature of a market where liquidity is king and fundamentals are an afterthought. The next 12 months will test three scenarios:
| Scenario | Trigger Event | Impact on AI Valuations | B2B Solutions in Demand |
|---|---|---|---|
| Soft Landing | Fed pauses rate hikes in H2 2026 | Valuations stabilize at 12x-15x revenue | Valuation adjustment firms refocus on DCF models |
| Correction | SEC enforces AI disclosure rules (Q4 2026) | 30%+ drawdown for non-profitable AI stocks | Financial crisis management teams surge |
| Crash | Major AI IPO fails (e.g., $10B+ valuation burns to $2B) | Liquidity freeze; secondary markets shut | Turnaround strategy consultants dominate |
The Bottom Line: Where to Turn When the Music Stops
Goldman’s Solomon is right—this isn’t fear driving markets. It’s greed, fueled by a perfect storm of dry powder, regulatory ambiguity, and the fear of missing out. The question isn’t *if* the correction will come, but *when*. For CFOs, VCs, and institutional investors navigating this chaos, the answer lies in proactive solutions:
- Pre-IPO AI firms: Engage AI-specific financial modeling firms to stress-test projections against SEC disclosure rules.
- Institutional investors: Partner with alternative investment hedging platforms to deploy synthetic shorts on overvalued AI ETFs.
- Corporate acquirers: Leverage distressed asset acquisition specialists to snap up AI assets at fire-sale prices.
The AI IPO wave is a ticking time bomb. The firms that survive won’t be the ones chasing the highest multiples—they’ll be the ones preparing for the fall. And when it happens, the World Today News Directory will be the first place to find the B2B partners who’ve already weathered the storm.